Form 4: Inogen Executive Reports Significant Stock Transactions
Insider Transaction Report
Inogen's EVP and Chief HR Officer, Jennifer M. Yi Boyer, reported multiple transactions involving common stock and restricted stock units, including vesting and tax-related dispositions.
Summary
- Jennifer M. Yi Boyer, EVP Enterprise Enablement and Chief HR Officer of Inogen Inc. (INGN), reported multiple transactions involving common stock and restricted stock units (RSUs).
- On February 27, 2026, a new grant of 32,500 restricted stock units was received, which will vest in three annual installments starting March 1, 2027.
- On March 1, 2026, a total of 25,020 shares of common stock were acquired through the vesting and conversion of various restricted stock unit awards (4,680 time-based, 3,603 performance-based, 7,332 time-based, and 13,005 time-based).
- Concurrently, 15,382 shares of common stock were disposed of to cover tax withholding liabilities associated with these vested awards, at a price of $6.1 per share.
- Following these transactions, Ms. Yi Boyer directly beneficially owns 26,747 shares of Inogen common stock and 65,842 restricted stock units.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine executive compensation and tax management, with the vesting of awards indicating continued service and achievement of performance conditions.
Positives
- Grant of 32,500 new restricted stock units on February 27, 2026, aligning executive incentives with long-term company performance.
- Vesting of 25,020 shares of common stock from various RSU awards on March 1, 2026, indicating continued service and achievement of performance conditions for the 2025 fiscal year for a portion of the awards.
Negatives
- Disposition of 15,382 shares of common stock at $6.1 per share to cover tax withholding liabilities, which reduces direct share ownership.
Future Outlook
The 32,500 restricted stock units granted on February 27, 2026, are scheduled to vest in three equal annual installments starting March 1, 2027. Remaining portions of other restricted stock unit awards are also scheduled to vest annually on March 1 in subsequent years, subject to continued service.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, providing transparency into executive stock ownership changes and compensation structures. These filings are standard for publicly traded companies and reflect ongoing executive incentive programs.
Stakeholder Impact
- Shareholders gain transparency into executive stock ownership and compensation, which can influence perceptions of management alignment with shareholder interests.
Next Steps
- Future vesting of the 32,500 restricted stock units in annual installments starting March 1, 2027.
- Future vesting of remaining tranches of other restricted stock unit awards on March 1 in subsequent years.
Key Dates
| Date | Description |
|---|---|
| 02/28/2023 | Grant date of the 2023 performance-based restricted stock unit award. |
| 03/01/2025 | Vesting commencement date for a portion of restricted stock units. |
| 02/27/2026 | Grant date of 32,500 new restricted stock units. |
| 03/01/2026 | Vesting date for multiple restricted stock unit awards and associated common stock transactions. |
| 03/03/2026 | Date the Form 4 was signed by Mary Wright, as Attorney-in-Fact. |
| 03/01/2027 | Vesting commencement date for the 32,500 restricted stock units granted on February 27, 2026, and for remaining tranches of other awards. |
Recommendation
holdThis Form 4 filing details routine executive compensation events, including RSU vesting and tax-related share dispositions. It does not present new information that would fundamentally alter the investment thesis for Inogen Inc, thus a 'hold' recommendation is appropriate based solely on this filing.
Keywords
Inogen, INGN, Form 4, Insider Trading, Stock Transactions, Restricted Stock Units, RSU, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.